Cardinal Health (NYSE:CAH) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Cardinal Health (NYSE:CAH) reported quarterly earnings of $2.08 per share, exceeding expectations by $0.05. Revenue was $60.16 billion, slightly below the forecast of $60.91 billion. The company had a net margin of 0.70% and a negative return on equity of 68.84%. Year-over-year, revenue increased by 0.5%. Cardinal Health updated its FY 2026 EPS guidance to 9.300-9.500. Analysts have generally rated the stock positively, with a consensus target price of $158.07 and a majority recommending a buy.
Cardinal Health (NYSE:CAH - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05, Briefing.com reports. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 EPS. The company's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health updated its FY 2026 guidance to 9.300-9.500 EPS.
Get Cardinal Health alerts:
Cardinal Health Stock Performance
- Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt
Cardinal Health stock opened at $158.07 on Tuesday. The stock has a fifty day moving average of $160.10 and a two-hundred day moving average of $144.16. The company has a market capitalization of $37.73 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 1.56 and a beta of 0.67. Cardinal Health has a fifty-two week low of $100.07 and a fifty-two week high of $168.44.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. Wells Fargo & Company raised Cardinal Health from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Robert W. Baird raised their price target on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a report on Tuesday. UBS Group reissued a "buy" rating on shares of Cardinal Health in a report on Tuesday. Finally, Citigroup reaffirmed a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $158.07.
- Medical Technology Stock Benefits from Rising Acute Care Demand
Check Out Our Latest Stock Analysis on Cardinal Health
Hedge Funds Weigh In On Cardinal Health
A hedge fund recently raised its stake in Cardinal Health stock. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 198.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,112 shares of the company's stock after purchasing an additional 14,034 shares during the quarter. Jones Financial Companies Lllp's holdings in Cardinal Health were worth $27,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.17% of the company's stock.
About Cardinal Health
(Get Free Report)- For Cardinal Health, the Proof Will be in Its Performance
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- How to Use the MarketBeat Excel Dividend Calculator
- MP Materials Stock Rides Rare Earth Boom to New Highs
- What Are Dividend Contenders? Investing in Dividend Contenders
- AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- IBM: The Last Time This Happened, the Stock Rallied 35%
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Cardinal Health Right Now?
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
